Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: Results of the oral enoximone in intravenous inotrope-dependent subjects trial

  • Arthur M. Feldman, Ron M. Oren, William T. Abraham, John P. Boehmer, Peter E. Carson, Eric Eichhorn, Edward M. Gilbert, Andrew Kao, Carl V. Leier, Brian D. Lowes, Michael A. Mathier, Frank A. McGrew, Marco Metra, Lawrence S. Zisman, Simon F. Shakar, Steven K. Krueger, Alastair D. Robertson, Bill G. White, Michael J. Gerber, Gwyn E. Wold, Michael R. Bristow
  • American Heart Journal, November 2007, Elsevier
  • DOI: 10.1016/j.ahj.2007.06.044

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1016/j.ahj.2007.06.044